Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05259_nanopub.RAtGyPwpPyZOCT4JJd5W2VQe4A5CdRVxm6p1GYCr2YIow#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB05259 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05259 label "Glatiramer Acetate [drugbank:DB05259]" assertion.
- drugbank:DB05259 seeAlso glatiramer.htm assertion.
- drugbank:DB05259 seeAlso glatiramer.html assertion.
- drugbank:DB05259 seeAlso DB05259 assertion.
- drugbank:DB05259 description "Glatiramer acetate consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000-9,000 daltons. It is an immunomodulator, licensed in much of the world for reduced frequency of relapses in relapsing-remitting multiple sclerosis" assertion.
- drugbank:DB05259 identifier "drugbank:DB05259" assertion.
- drugbank:DB05259 title "Glatiramer Acetate" assertion.
- drugbank:DB05259 drugbank_vocabulary:x-cas cas:147245-92-9 assertion.
- drugbank:DB05259 drugbank_vocabulary:drugbank-id "APRD00999" assertion.
- drugbank:DB05259 drugbank_vocabulary:drugbank-id "DB05259" assertion.
- drugbank:DB05259 bio2rdf_vocabulary:x-identifiers.org DB05259 assertion.
- drugbank:DB05259 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05259" assertion.
- drugbank:DB05259 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05259 bio2rdf_vocabulary:identifier "DB05259" assertion.
- drugbank:DB05259 drugbank_vocabulary:x-wikipedia wikipedia:Glatiramer_acetate assertion.
- drugbank:DB05259 drugbank_vocabulary:x-pharmgkb pharmgkb:PA449760 assertion.
- drugbank:DB05259 drugbank_vocabulary:x-dpd dpd:2233014 assertion.
- drugbank:DB05259 drugbank_vocabulary:x-atc atc:L03AX13 assertion.
- drugbank:DB05259 drugbank_vocabulary:x-ndc ndc:0088-1153-30 assertion.